Allurion Technologies (ALUR) Research & Development (2022 - 2026)
Allurion Technologies (ALUR) posted Research & Development of $1.3 million for Q1 2026, up 15.3% on a QoQ basis from $1.1 million in Q4 2025, and down 63.99% year-over-year from $3.6 million in Q1 2025.
Allurion Technologies (ALUR) Research & Development (2022 - 2026) Analysis & Trends
Allurion Technologies' Research & Development history runs 5 years deep, the most recent figure standing at $1.3 million for Q1 2026.
- Quarterly Research & Development fell 63.99% year-over-year to $1.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.9 million (down 67.97% YoY) and the FY2025 annual result came in at $7.6 million, down 70.81% from the prior year.
- Research & Development was $1.3 million for Q1 2026 at Allurion Technologies, up from $1.1 million in the prior quarter.
- Across five years, Research & Development topped out at $39.2 million in Q4 2022 and bottomed at $1.1 million in Q4 2025.
- A 5-year average of $8.2 million and a median of $6.4 million in 2023 frame the typical range for Research & Development.
- Annual changes were most pronounced in 2024 — Research & Development gained 29.68% — and 2025, when it slumped 85.63%.
- Allurion Technologies' Research & Development stood at $39.2 million in 2022, then tumbled by 84.5% to $6.1 million in 2023, then increased by 29.68% to $7.9 million in 2024, then slumped by 85.63% to $1.1 million in 2025, then increased by 15.3% to $1.3 million in 2026.
- Business Quant data shows ALUR's Research & Development at $1.3 million in Q1 2026, $1.1 million in Q4 2025, and $2.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 767.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 413.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 671.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 516.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 263.30 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 145.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -461.27 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 345.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Allurion Technologies | 74.67 Mn | 69.62 Mn | 1.23 Mn | 1.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.30 Mn |
| Dec 31, 2025 | 1.13 Mn |
| Sep 30, 2025 | 2.02 Mn |
| Jun 30, 2025 | 2.41 Mn |
| Mar 31, 2025 | 3.62 Mn |
| Dec 31, 2024 | 7.87 Mn |
| Sep 30, 2024 | 3.21 Mn |
| Jun 30, 2024 | 6.72 Mn |
| Mar 31, 2024 | 6.15 Mn |
| Dec 31, 2023 | 6.07 Mn |
| Sep 30, 2023 | 7.19 Mn |
| Jun 30, 2023 | 6.58 Mn |
| Mar 31, 2023 | 11.86 Mn |
| Dec 31, 2022 | 39.17 Mn |
| Sep 30, 2022 | 15.69 Mn |
| Jun 30, 2022 | 10.91 Mn |